A carregar...
Immune checkpoint inhibitor-induced musculoskeletal manifestations. A multicentre prospective study
BACKGROUND: Immune checkpoint inhibitors (ICI) are anti-cancer drugs that act by enhancing anti-tumour immunity. Due to their mechanism of action, they have been associated with immune related adverse events (Ir-AE), including musculoskeletal manifestations. AIM: To assess a) the prevalence, clinica...
Na minha lista:
| Publicado no: | Mediterr J Rheumatol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Mediterranean Journal of Rheumatology (MJR)
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7362123/ https://ncbi.nlm.nih.gov/pubmed/32676566 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31138/mjr.31.2.239 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|